• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物在血浆中平均驻留时间的测定以及初始药物消除和分布对药代动力学参数计算的影响。

Determination of mean residence time of drug in plasma and the influence of the initial drug elimination and distribution on the calculation of pharmacokinetic parameters.

作者信息

Berezhkovskiy Leonid M

机构信息

Genetech Inc, South San Francisco, California 94080, USA.

出版信息

J Pharm Sci. 2009 Feb;98(2):748-62. doi: 10.1002/jps.21440.

DOI:10.1002/jps.21440
PMID:18506769
Abstract

The equation for the calculation of mean residence time of drug in plasma, t(p), is obtained. It is shown that the previously suggested calculation of t(p) considerably overestimates the true value in most cases. It is suggested that due to the possible initial (before establishing the uniform drug mixing in plasma) fast elimination of drug, the commonly calculated total body clearance (Cl = D/AUC) may substantially overestimate the clearance in the linear range of elimination of well-stirred drug. This would result in the high in vivo Cl values that are not supported by the in vitro studies of drug metabolism and stability in tissues. It is shown that the mean residence time of drug in the body, volumes of distribution, oral bioavailability and distribution clearance estimated with the account of initial drug distribution and elimination, may substantially deviate from the values obtained by the traditional calculations.

摘要

得出了计算药物在血浆中平均驻留时间t(p)的方程。结果表明,先前建议的t(p)计算方法在大多数情况下会显著高估真实值。研究表明,由于药物可能在初始阶段(在血浆中建立均匀药物混合之前)快速消除,通常计算的总体清除率(Cl = D/AUC)可能在药物线性消除范围内大幅高估清除率。这将导致体内Cl值过高,而这在药物代谢和组织稳定性的体外研究中并未得到支持。结果表明,考虑初始药物分布和消除后估算的药物在体内的平均驻留时间、分布容积、口服生物利用度和分布清除率,可能与传统计算得到的值有很大偏差。

相似文献

1
Determination of mean residence time of drug in plasma and the influence of the initial drug elimination and distribution on the calculation of pharmacokinetic parameters.药物在血浆中平均驻留时间的测定以及初始药物消除和分布对药代动力学参数计算的影响。
J Pharm Sci. 2009 Feb;98(2):748-62. doi: 10.1002/jps.21440.
2
On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.传统非房室方程估算基本药代动力学参数的准确性及基于正常受试者数据预测肥胖患者稳态分布容积。
J Pharm Sci. 2011 Jun;100(6):2482-97. doi: 10.1002/jps.22444. Epub 2011 Jan 19.
3
The influence of drug kinetics in blood on the calculation of oral bioavailability in linear pharmacokinetics: the traditional equation may considerably overestimate the true value.线性药代动力学中血液药物动力学对口服生物利用度计算的影响:传统公式可能会显著高估真实值。
J Pharm Sci. 2006 Apr;95(4):834-48. doi: 10.1002/jps.20570.
4
Prediction of drug terminal half-life and terminal volume of distribution after intravenous dosing based on drug clearance, steady-state volume of distribution, and physiological parameters of the body.基于药物清除率、稳态分布容积和机体生理参数预测静脉给药后的药物末端半衰期和末端分布容积。
J Pharm Sci. 2013 Feb;102(2):761-71. doi: 10.1002/jps.23396. Epub 2012 Dec 11.
5
On the accuracy of calculation of the mean residence time of drug in the body and its volumes of distribution based on the assumption of central elimination.基于中央消除假设对药物在体内的平均驻留时间及其分布容积计算的准确性
Xenobiotica. 2016;46(6):477-82. doi: 10.3109/00498254.2015.1089366. Epub 2015 Sep 25.
6
Conceptual underestimation of the total body clearance by the sum of clearances of individual organs in physiologically based pharmacokinetics.在生理药代动力学中,通过各个器官清除率的总和来估算总体清除率会产生概念性低估。
J Pharm Sci. 2012 Dec;101(12):4660-5. doi: 10.1002/jps.23327. Epub 2012 Sep 21.
7
Use of unbound volumes of drug distribution in pharmacokinetic calculations.在药代动力学计算中使用未结合药物分布容积。
Eur J Pharm Sci. 2011 Jan 18;42(1-2):91-8. doi: 10.1016/j.ejps.2010.10.011. Epub 2010 Nov 2.
8
Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination.具有外周消除的线性药代动力学系统的稳态分布容积。
J Pharm Sci. 2004 Jun;93(6):1628-40. doi: 10.1002/jps.20073.
9
Prediction of the possibility of the secondary peaks of iv bolus drug plasma concentration time curve by the model that directly takes into account the transit time through the organ.通过直接考虑器官内通过时间的模型来预测静脉推注药物血药浓度时间曲线二次峰的可能性。
J Pharm Sci. 2009 Nov;98(11):4376-90. doi: 10.1002/jps.21715.
10
The influence of hepatic transport on the distribution volumes and mean residence time of drug in the body and the accuracy of estimating these parameters by the traditional pharmacokinetic calculations.肝转运对药物在体内分布容积和平均驻留时间的影响,以及传统药代动力学计算估算这些参数的准确性。
J Pharm Sci. 2011 Nov;100(11):5031-47. doi: 10.1002/jps.22696. Epub 2011 Jul 15.

引用本文的文献

1
Red Blood Cell Membrane Vesicles for siRNA Delivery: A Biocompatible Carrier With Passive Tumor Targeting and Prolonged Plasma Residency.用于小干扰RNA递送的红细胞膜囊泡:一种具有被动肿瘤靶向性和延长血浆驻留时间的生物相容性载体
Int J Nanomedicine. 2025 Mar 15;20:3269-3301. doi: 10.2147/IJN.S504644. eCollection 2025.
2
Covalent IR820-PEG-diamine nanoconjugates for theranostic applications in cancer.用于癌症诊疗应用的共价IR820-聚乙二醇-二胺纳米共轭物
Int J Nanomedicine. 2014 Oct 6;9:4631-48. doi: 10.2147/IJN.S69550. eCollection 2014.